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Background: Understanding contraception from the perspective of the user may help to improve compliance. The
aim of this project was to determine the factors that influence the noncompliance in young women that use
combined hormonal contraceptives (pill, patch or vaginal ring).
Methods: A nationwide cross-sectional multicenter epidemiology study. Physicians [obstetricians/gynecologists])
recorded socio-demographic, clinical and current contraception data of 8,762 women. Women completed a self-
administered questionnaire on compliance. After the assessment of self-administrated questionnaire, the physicians
reported on their recommendations on the possibility of changing the contraceptive.
Results: Fifty-two percent of women were noncompliant, mainly because of simple forgetfulness (pill, 74.9%; patch,
47.8%; vaginal ring, 69.1%). The percentage of noncompliant women was lower in vaginal ring users (26.6%) than in
patch users (42.4%) or pill users (65.1%) (p < 0.0001). The most common course of action after noncompliance was
to take/use the contraceptive as soon as possible. In the multiple logistic regression analysis, the use of the pill
increased the probability of noncompliance compared with the patch and the vaginal ring (odds ratio [IC95%]: 2.53
(2.13-3.02) and 4.17 (3.68-4.73, respectively), and using the patch compared with the vaginal ring (1.65 (1.36-1.99)).
Others factors associated with noncompliance were: high treatment duration, low degree of information on the
contraceptive method, understanding of instructions on the contraceptive method, indifference to becoming
pregnant, lack of partner support, not participation in selecting the method, not having a routine for taking
treatment and difficulties remembering use the contraceptive method. Switching contraceptive method was
proposed by the physicians to 43.2% of women (51.8% of pill users, 58.2% of patch users and 19.4% of vaginal ring
users).
Conclusions: More than 50% of combined hormonal contraceptive users did not comply with the treatment
regimen. The percentage of noncompliant women was lower between vaginal ring users. Understanding user’s
reasons for noncompliance by the clinician and encouraging a collaborative approach can go a long way to
improving compliance.
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4.7 million European women aged 15–49 are estimated
to be at risk of an unintended pregnancy [1]. A national
survey in Spain showed that, although 69.1% of women
of childbearing age used some type of contraception [2],
the efficacy of the method was poor in 5% of the cases.
In addition, 30.9% of women did not use any method,
leaving more than 1 million women at risk of unin-
tended pregnancy. The consequences of noncompliance
are far reaching. According to Darney [3], almost half of
the 6.3 million pregnancies in the US are unintended,
despite the availability of a wide variety of highly effect-
ive contraceptive methods.
Combined oral hormonal contraceptives are a safe and
efficacious method of protection against unintended
pregnancy. However, they are not always used consist-
ently [4], and as many as 47% of women using combined
oral contraceptives in the United States miss at least 1
pill per cycle [5]. A European study showed that 19% of
women aged 16 to 30 years missed 1 or more pills per
cycle and those women were 2.6 times more likely to
have an unintended pregnancy than the ones who miss
less than 1 pill per cycle [6]. The efficacy of oral contra-
ception depends on continued intake [6]. In many cases,
poor compliance can be attributed to human factors [7],
such as lack of a fixed routine for pill taking, misinter-
pretation of the information in the package insert, scant
advice from health care providers, and side effects (eg,
bleeding irregularities, nausea, and breast tenderness)
[6]. Incorrect pill taking can lead to discontinuation and
unintended pregnancy [4,8].
Therefore, methods that reduce the frequency of dosing
could increase compliance [8]. Alternative delivery methods
for combined hormonal contraceptives have been devel-
oped over the years; such as the transdermal patch and the
vaginal ring [9]. Matters of convenience seem to be espe-
cially important for women when selecting the patch or
ring. Both offer advantages over the pill; for example, they
can be used weekly or monthly, are easy of use and have
lower likelihood of forgetting it [10].
Women’s perceptions influence their contraceptive de-
cisions. Indeed, poor compliance generates a significant
care burden in terms of user’s anxiety about preventing
pregnancy and an increase of visits to the gynecologist
for advice [11]. To support informed contraceptive
decision-making, healthcare professionals should realize
that the perception women have on the method’s ease of
use is more important than perceived efficacy, tolerabil-
ity, health benefits or risks [10].
Acceptance of the vaginal ring has been shown to be
higher (46%) than for the pill (39%) and skin patch (15%),
mainly because of the lower probability of inadvertent
omission [12]. In addition, the efficacy and tolerability pro-
file of the vaginal ring is comparable to that of combinedoral contraceptives [13], and women are more likely to con-
tinue using it than women who take a combined oral
contraceptive [14]. Other authors report the degree of satis-
faction with the transdermal patch to be higher than with
other delivery methods [15].
Studying the reasons for noncompliance enables us to
understand contraception from the point of view of the
user, and some authors have assessed the self-reported
impact of noncompliance, which may have a negative
impact in the user’s behavior in front of working activ-
ities and/or with their couple [11].
The primary objective of the study was to determine what
factors are associated with noncompliance in two types of
user: 1) young women (18–28 years) or 2) women with lit-
tle experience of combined hormonal contraceptives (max-
imum 2 years before the visit), in the case of women over
28 years.
The analyzed data about the advice given to users by
the gynecologists and the level of acceptance of this ad-
vice should place clinicians in a better position to help
women select the most suitable method for them or to
recommend a more effective method when necessary.
The study describes the profile of the noncompliant
user and presents the advice given by the gynecologist
depending on the degree of noncompliance, user profile
and reasons for noncompliance.
Methods
In order to analyze compliance with contraceptive use a
nationwide cross-sectional multicenter study was
performed. Subjects were recruited both in centers of
the Spanish National Health Service and in private
health centers. Since the primary endpoint of the study
was to describe the factors associated with noncompli-
ance and these would only be described by the noncom-
pliant user; the size of the sample must be estimated
taking into account the market share in Spain of the
various contraceptive methods and the estimated per-
centage of noncompliant users for each of them (REMO
Study: 71% pill, 32% patch and 21.6% vaginal ring) [11].
Based on the estimated market share in Spain of various
studies of contraceptive methods (pill 74%, patch 7%, va-
ginal ring 19%) and an assumption of an overlap of 80%
between the 2 types of user (young women and women
with little experience of their contraceptive method) a
total of 12,000 users was calculated to be necessary to
guarantee a minimum sample of 380 per group (pill,
patch or vaginal ring) with a margin of error of 5% and
a maximum uncertainty in noncompliance (p = q = 0.5),
even in the least used method (patch).
In order for women being included in the study they had
to be currently using a combined hormonal contraceptive
(pill, patch or vaginal ring). In addition, women had to meet
at least one of the following inclusion criteria: 1) had to be
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chosen contraceptive method (maximum 2 years before the
visit). Women participating in a clinical trial or who were
not capable of completing the questionnaire (investigator
criteria) were excluded.
Data were collected from the clinical history at a single
routine visit to the gynecologist [see Additional file 1]. The
physician recorded sociodemographic data (age, educa-
tional level, occupational status, stable partner), obstetric
history (number of births, abortions [spontaneous and in-
duced], number of live childbirths), and data on the current
contraceptive method. A self-administered questionnaire
on contraceptive compliance was completed by the woman
during the visit. The type of questionnaire varied according
to whether they used pill, patch, or vaginal ring. A lack of
strict compliance was evaluated by means of questions on
forgetting to take the contraceptive, taking the contracep-
tive late, discontinuing the contraceptive, and incorrect use
of the contraceptive. In cases of noncompliance, the
woman was asked about the reasons and circumstances
that led to noncompliance.
A compliant user was defined as a woman who always
used her contraceptive method without no delays or
omissions, according to the question in the self-
administered questionnaire “Have you delayed/forgotten
sometime in the use of your contraceptive method?
(Yes/No)”. A noncompliant user was defined as one who
missed or delayed using her contraceptive method at
least once since the last visit. Delay was defined
according to the Summary of Product Characteristics of
each method.
Finally, after assessing the self-administered question-
naire, taking into account the user’s profile, the degree of
noncompliance and its reasons, the gynecologist recorded
his/her recommendation at the visit, as was the woman’s
acceptance or rejection of the recommendation and the
current type of contraception and the type that was
recommended. If a change of method was recommended,
the reason for this recommendation was indicated too.
The Ethics Committee of Hospital Clínic (Barcelona,
Spain) approved the study according to the legislation in
force at the time (Spanish Ministerial Order SAS/3470/
2009), and all the patients gave their written informed
consent to participate.
The characteristics of the women were described using
a frequency table for categorical variables and measures
of central tendency and dispersion for continuous vari-
ables. A bivariate analysis was performed to describe
women’s profile in terms of the contraceptive method
used. Contingency tables (of categorical variables) were
analyzed using the chi-squared test or Fisher exact test.
Continuous variables were analyzed using a t test or an
analysis of variance, as long as the normality assumption
was satisfied; non-normally distributed variables wereanalyzed using a nonparametric method (Wilcoxon-
Mann–Whitney or Kruskal-Wallis) for independent
samples. A multiple logistic regression analysis (stepwise
method) was performed to determine the factors that
affect whether a woman is compliant or not. Statistical
significance was set at a 2-sided p-value of < .05. The
statistical analysis was performed using SAS v.9.2 (SAS
Institute Inc., Cary, North Carolina, USA).
Results
The gynecologists collected data of 9,367 women, from
which 8.762 (93.5%) met inclusion criteria (1. young
women [18–28 years] or 2. women over 28 years with
little experience of combined hormonal contraceptives
(maximum 2 years before the visit)).
Mean (SD) age was 25.3 (4.8) years and most of the
women were nulligravid. In addition, 57.3% worked out-
side the home and 27.2% were students (Table 1). The
most commonly used contraceptive method was the pill
(61.9%), followed by the vaginal ring (28.4%) and the
patch (9.8%). The pill had also been used for a longer
period of time than the other methods (mean
30.8 months vs 19.3 and 21.6 months for the patch and
vaginal ring, respectively [p < 0.0001]).
According to the definitions in the Material and
methods section, 52.0% of women were noncompliant,
with significant differences depending on the type of
contraception used (p < 0.0001) (Figure 1).
The most common reasons for omission/delay of using
a contraceptive method were simple forgetfulness
(Table 1), with differences observed between contracep-
tive methods (p < 0.0001). Specific reasons of each
contraceptive method included the desire to hasten the
occurrence of /postpone withdrawal bleeding (13.6%)
and accidental expulsion (6.9%) in women using the va-
ginal ring. In the case of the patch, the reasons included
accidental detachment without the user realizing
(29.4%), acne and discomfort when sand got below the
patch. In pill users, the reasons included not being in
the right place, hastening the occurrence of withdrawal
bleeding and rest period.
Most women had a routine to remind them to take/
use their contraceptive method, observing statistically
significant differences between the contraceptive method
used (p < 0.0001). Remembering to use the contraceptive
method was more difficult on vacation (31.3%), espe-
cially in vaginal ring users (p < 0.0001), during the week-
end (27.7%) and after going out the previous night
(12.9%), especially in pill users (p < 0.0001). Women also
found it difficult to use their contraceptive during trips
to different time zone areas (p < 0.0001) (Table 1).
The most common course of action after noncompli-
ance was to use the contraceptive as soon as possible.
Women also consulted a health care provider, especially
Table 1 Profile of the study population according to delivery system
Total Pill Patch Ring p Value
Age, years (mean (SD)) 25.29 (4.79) 25.14 (4.81) 25.49 (4.78) 25.56 (4.71) <0.0001a
Time using the current method, months (mean (SD)) 27.08 (24.84) 30.83 (28.40) 19.28 (15.07) 21.57 (16.01) <0.0001a
Obstetric history (mean (SD))
Pregnancies 0.36 (0.79) 0.36 (0.79) 0.52 (0.87) 0.32 (0.75) <0.0001a
Deliveries 0.26 (0.60) 0.26 (0.60) 0.37 (0.71) 0.22 (0.56) <0.0001a
Abortions (spontaneous) 0.05 (0.26) 0.05 (0.25) 0.09 (0.35) 0.05 (0.23) 0.001a
Abortions (induced) 0.08 (0.35) 0.09 (0.38) 0.12 (0.38) 0.06 (0.27) <0.0001a
Live childbirths 0.17 (0.50) 0.17 (0.50) 0.22 (0.58) 0.14 (0.47) 0.0004a
Stable partner
Yes 7,106 (82.1%) 4,367 (81.5%) 679 (80.6%) 2,060 (83.9%) <0.0153b
No 1,549 (17.9%) 991 (18.5%) 164 (19.5%) 394 (16.1%)
Education <0.0001b
Primary 934 (10.8%) 655 (12.2%) 109 (12.9%) 170 (6.9%)
Secondary 3,885 (44.8%) 2,479 (46.2%) 406 (47.9%) 1,000 (40.5%)
University 3,863 (44.5%) 2,233 (41.6%) 333 (39.3%) 1,297 (52.6%)
Occupational status <0.0001b
Working outside the home 4,960 (57.3%) 3,018 (56.28%) 476 (56.4%) 1,466 (59.6%)
Homemaker 561 (6.5%) 363 (6.8%) 90 (10.7%) 108 (4.4%)
Student 2,353 (27.2%) 1,451 (27.1%) 208 (24.6%) 694 (28.2%)
Unemployed 790 (9.1%) 530 (9.9%) 70 (8.3%) 190 (7.7%)
Reasons for omission/delay
Forgetfulness/delays 2,622 (71.2%) 1,996 (74.9%) 172 (47.8%) 494 (69.1%) <0.0001b
Altered libido 214 (5.8%) 180 (6.8%) 14 (3.9%) 20 (3.0%) 0.0003b
Weight gain 211 (5.7%) 201 (7.5%) 4 (1.1%) 6 (0.9%) <0.0001b
Common course of action after noncompliance
Use the contraceptive as soon as possible 2,396 (65.1%) 1,745 (65.5%) 235 (65.3%) 416 (63.3%) 0.5868 b
Consult a health care provider 598 (22.1%) 337 (16.2%) 76 (14.1%) 145 (21.1%) <0.0001b
Use two or more methods to compensate for the days missed 353 (9.6%) 339 (12.7%) 5 (1.4%) 9 (1.4%) <0.0001b
Routine method <0.0001b
At the same time every day 5,837 (67.6%) 3,621 (67.6) 515 (61.0%) 1,701 (70.0%)
Daily task 1,472 (17.1%) 933 (17.4) 168 (19.9%) 371 (15.3%)
Thinking of it but not yet organized 712 (8.3%) 514 (9.6%) 85 (10.1%) 113 (4.7%)
Not interested 183 (2.1%) 117 (2.2%) 38 (4.5%) 28 (1.2%)
Others 429 (5.0%) 174 (3.3%) 38 (4.5%) 217 (8.9%)
Difficulties remembering to use the contraceptive method
During the week, from Monday to Friday 856 (9.8%) 510 (9.4%) 86 (10.1%) 260 (10.5%) 0.3234 b
On vacation 2,745 (31.3%) 1,531 (28.2%) 279 (32.6%) 935 (37.6%) <0.0001b
On weekend 2,426 (27.7%) 1,889 (34.8%) 175 (20.4%) 362 (14.6%) <0.0001b
On short trips 966 (11.0%) 606 (11.2%) 101 (11.8%) 259 (10.4%) 0.4592 b
Going out the night before 1,127 (12.9%) 863 (15.9%) 114 (13.3%) 150 (6.0%) <0.0001b
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Figure 1 Compliance/noncompliance according to the
contraceptive method used.
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women taking the pill used two or more methods to
compensate for the days missed compared with 1.4% for
women using the vaginal ring (p < 0.0001). The next
most common decision was to do nothing, more often
between pill users (p < 0.0001).
The compliance comparison showed that the amount
of time using the current method (months) was higher
in noncompliant women than in compliant ones(24.8
compliant women vs 29,1 noncompliant women; p <
0.0001), and that the degree of information and degree
of understanding the information and instructions of the
used method were lower in noncompliant women com-
pared to compliant women. More than half of the
women (51.1%) believe that if they could participate in
the choice of the contraceptive method they would have
less forgetfulness/delays, mainly noncompliant women
compared with compliant women (57.0% vs 44.1%,
p <0.0001). The partner support and interest in not be-
coming pregnant were also lower in noncompliant
women. Not having a routine or having difficulties re-
membering to use the contraceptive method involves
higher noncompliance (Table 2).
A multiple logistic regression analysis (stepwise
method) was performed to determinate which factors
might affect the probability of noncompliance of a user
(Table 3). The analysis revealed that the length of time
using the contraceptive method was likely to play a role
in the noncompliance therapy [OR (95%CI): 1.006
(1.004-1.008), p < 0.0001]. Depending on the contracep-
tive method the level of noncompliance can be higher
(p < 0.0001): using pill increased the probability of non-
compliance compared with the patch [OR (95%CI): 2.53
(2.13-3.02)] and compared with the vaginal ring [OR
(95%CI) 4.18 (3.68-4.73)], and the use of patch increased
the probability of noncompliance [OR (95%CI): 1.65(1.36-1.99)] compared with the vaginal ring. Low level of
user’s information treatment and a poor understanding
of information and instructions were also associated
with a higher probability of noncompliance. Compared
with women interested not becoming pregnant, the
probabilities of noncompliance increased for women
preferring to not get pregnant [OR (95%): 1.27 (1.06-
1.53)] and women who would not mind [OR (95%): 1.46
(1.00-2.12)]. Having a partner indifferent to a possible
pregnancy or the absence of a partner also increased the
probability of noncompliance. Moreover, the lack of sup-
port from one’s partner or the absence of a partner was
also a factor that may affect the noncompliance in-
creased. The probability of noncompliance was higher in
women who think that if they could participate in the
decision to choose the contraceptive method would have
fewer delays/omissions, that it, they would be more
compliant.
The use of a method to remember the medication
was another factor associated with the noncompli-
ance. Not being interested in a routine method, hav-
ing considered it but not being organized yet and
doing an activity that provided a reminder on treat-
ment increased the noncompliance compared always
taking or applying the medication always at the same
hour.
Finally, the noncompliance increased in women with
difficulties remembering to take/use/remove the contra-
ceptive method: during the week (Monday-Friday), on
weekends, on vacation, on short trips, after going out
the night before and when travelling to a different time
zone).
A recommendation for switching was made regardless
of the current method (43.2%), although this recom-
mendation was made to a lower percentage of women
using the vaginal ring than to the other groups (pill,
51.8%; patch, 58.2%; vaginal ring, 19.4%). The reasons
given by the gynecologist for switching method varied
according to the current method and the degree of
compliance. Patients were advised to switch to the pill
for reasons of tolerance. In the case of the patch or
vaginal ring, the switch was recommended for reasons
of convenience in compliers and for reasons of compli-
ance in noncompliers.Discussion
The study analyzed 3 widely used contraceptive methods
in a sample that was sufficiently large to enable to
present the results with a significant degree of precision
(the precision reached with the final sample was 1%. It
is not significantly difference from the initially proposed
sample −0.9%-). Most of the women in the study used
the pill (61.9%), a finding that is consistent with the
Table 2 Profile of the study population according to compliance
Total Compliant Noncompliant p Value
Age, years (mean (SD)) 25.29 (4.79) 25.50 (4.77) 25.10 (4.79) <0.0001a
Time using the current method, months (mean (SD)) 27.08 (24.84) 24.82 (23.28) 29.16 (26.04) <0.0001a
Obstetric history (mean (SD))
Pregnancies 0.36 (0.79) 0.35 (0.74) 0.38 (0.83) <0.3966a
Deliveries 0.26 (0.60) 0.25 (0.57) 0.27 (0.63) <0.5212a
Abortions (spontaneous) 0.05 (0.26) 0.05 (0.26) 0.05 (0.26) <0.7648a
Abortions (induced) 0.08 (0.35) 0.06 (0.27) 0.10 (0.42) <0.0001a
Live childbirths 0.17 (0.50) 0.15 (0.47) 0.18 (0.53) 0.0436a
Stable partner <0.0001b
Yes 7,106 (82.1%) 3,525 (84.9%) 3,581 (79.5%)
No 1,549 (17.9%) 628 (15.1%) 921 (20.5%)
Education <0.0001c
Primary 934 (10.8%) 358 (8.6%) 576 (12.8%)
Secondary 3,885 (44.8%) 1,817 (43.6%) 2,068 (45.8%)
University 3,863 (44.5%) 1,993 (47.8%) 1,870 (41.4%)
Occupational status <0.0003c
Working outside the home 4,960 (57.3%) 2,474 (59.5%) 2,486 (55.2%)
Homemaker 561 (6.5%) 244 (5.9%) 317 (7.0%)
Student 2,353 (27.2%) 1,091 (26.2%) 1,262 (28.0%)
Unemployed 790 (9.1%) 349 (8.4%) 441 (9.8%)
Information on treatment <0.0001c
Very informed 902 (44.8%) 2,309 (55.2%) 1,593 (35.1%)
Normal 4,495 (51.5%) 1,814 (43.4%) 2,681 (59.2%)
Not very informed 307 (3.5%) 61 (1.4%) 246 (5.4%)
Not interested 15 (0.2%) 0 (0%) 15 (0.3%)
Understanding of information and instructions <00001c
Not interested 11 (0.1%) 2 (0.05%) 9 (0.2%)
Anything 20 (0.2%) 4 (0.1%) 16 (0.4%)
Not understanding a lot of things 393 (4.5%) 70 (1.7%) 323 (7.1%)
Understanding almost all 2,719 (31.2%) 1,046 (24.9%) 1,673 (36.9%)
Complete understanding 5,587 (64.1%) 3,076 (73.3%) 2,511 (55.4%)
Partner support <.0001c
Always reminding 2,992 (34.3%) 1,724 (41.2%) 1,268 (28.1%)
Absence of partner 1,128 (13.0%) 458 (10.9%) 670 (14.8%)
Indifferent 1,349 (15.5%) 540 (12.9%) 809 (17.9%)
Sometimes 3,239 (37.2%) 1,467 (35.0% 1,772 (39.2%)
Interest in not becoming pregnant <.0001c
Very interested 5,823 (66.7%) 2,893 (68.9%) 2,930 (64.6%)
Interested 1,551 (17.8%) 737 (17.6%) 814 (18.0%)
Prefer not to get pregnant 1,174 (13.5%) 489 (11.7%) 685 (15.1%)
Not mind 179 (2.0%) 76 (1.8%) 103 (2.3%)
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Table 2 Profile of the study population according to compliance (Continued)
Belief that participation would avoid forgetfulness/delays <0.0001c
More 564 (6.6%) 349 (8.6%) 215 (4.8%)
The same 3,613 (42.3%) 1,905 (46.9%) 1,708 (38.2%)
Less 4,357 (51.1%) 1,808 (44.5%) 2,549 (57.0%)
Routine method
At the same time every day 5,837 (67.6%) 2,990 (72.1%) 2,847 (63.5%) < 0.0001c
Daily task 1,472 (17.1%) 746 (18.0%) 726 (16.2%)
Thinking of it but not yet organized 712 (8.3%) 96 (2.3%) 616 (13.7%)
Not interested 183 (2.1%) 60 (1.5%) 123 (2.7%)
Other 429 (4.3%) 254 (6.1%) 175 (3.9%)
Difficulties remembering to take/use/remove the contraceptive method
During the week, from Monday to Friday 856 (9.8%) 221 (5.3%) 635 (14.0%) < 0.0001b
On vacation 2,745 (31.3%) 1,372 (32.6%) 1,373 (30.2%) 0.015 b
On weekend 2,426 (27.7%) 756 (18.0%) 1,670 (36.7%) < 0.0001b
On short trips 966 (11.0%) 492 (11.7%) 474 (10.4%) 0.0604b
Going out the night before 1127 (12.9%) 422 (10.0%) 705 (15.5%) < 0.0001b
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from 5 European countries [1].
Compliance varies according to the delivery method
chosen. That the study showed that more than half (52.0%)
of the women do not apply their contraceptive method
according to the instructions in the package insert, espe-
cially in pill users. The main reason for missing/delays in
using the contraceptive method in the study was simple
forgetfulness, although some women complained of side ef-
fects such as altered libido or weight gain. A large noncom-
pliance rate and women's difficulties in maintaining safe
contraception after missing a pill were observed in others
studies [16,17]. Westhoff et al. [18] found that most women
discontinued for reasons not associated with side effects.
One study showed that compliance was greater with the va-
ginal ring than with the pill [19], whereas others show con-
sistent perfect compliance with the transdermal patch
[20,21].
Not having a regular routine has been shown to be one
of the strongest risk factors for poor compliance. Women
who do not have a regular routine for pill taking are more
than 3 times more likely to be inconsistent users [6]. Mem-
ory aids such as associating pill taking with another daily
action or leaving the pill package visible, have also been as-
sociated with easier compliance [22].
The study shows that not having a stable partner in-
creased noncompliance. Whenever both members of a
couple are convinced that they do not want a pregnancy,the participation of the partner has been shown to be ef-
fective in increasing adherence [23]. This study, in agree-
ment with other studies, also demonstrated that the low
level of information on the contraceptive treatment and
poor understanding of information and instruction influ-
ence noncompliance [24].
Indeed, several authors have shown that the quality of
family planning counseling could affect continuation
with a particular method [25]. Halpern et al. [7] sug-
gested that, while enhanced counseling has a limited ef-
fect on continuation, it could change the reasons why
women discontinue contraception. Furthermore, Grove
and Hooper [26] stress the need for physicians to make
recommendations that are tailored to a woman’s medical
profile and preferences.
The relationship with the health care provider is para-
mount in ensuring compliance, and one study of adoles-
cent women showed that if the physician was considered
to be helpful, then users were more compliant [27].
In addition, the physician must be able to provide an
alternative method, should compliance prove difficult
with the initially chosen one [28]. In this study, a recom-
mendation for switching was made by the clinician after
analyzing the reasons for noncompliance of the users, al-
though this recommendation was made to a lower per-
centage of women using the vaginal ring than to the
other groups (pill, 51.8%; patch, 58.2%; vaginal ring,
19.4%).
Table 3 Multiple logistic regression analysis
Factor OR estimate OR 95% CI p-value
Time using the current method, months (continuous variable) 1.006 1.004–1.008 <0.0001
Contraceptive method Pill vs vaginal ring 4.175 3.683–4.732 <0.0001
Patch vs vaginal ring 1.648 1.362–1.994
Pill vs Patch 2.534 2.128–3.016
Information on treatment Not very informed 1.931 1.336–2.791 <0.0001
(reference: very informed) Normal 1.532 1.370–1.713
Interest in not becoming pregnant Very interested 1.161 1.012–1.332 <0.0001
(reference: interested) Prefer not to get pregnant 1.273 1.057–1.534
Not mind 1.455 1.001–2.117
Partner support Absence of partner 1.415 1.195–1.676 <0.0001
(reference: always reminding) Indifferent 1.416 1.205–1.664
Sometimes 1.372 1.214–1.550
Understanding of information and instructions Not interested 2.137 0.182–25.052 0.0089
(reference: complete understanding) Anything 1.066 0.283–4.014
Not understanding a lot of things 1.696 1.213–2.371
Understanding almost all 1.167 1.032–1.318
Belief that participation would avoid forgetfulness/delays More vs The same 1.072 0.865–1.329 <0.0001
Less vs The same 1.298 1.167–1.444
Less vs More 1.211 0.977–1.501
Routine method Other 1.142 0.902–1.447 <0.0001
(reference: at the same hour each day of the week/month) Not interested 1.470 1.003–2.154
Considered but not organized 3.873 2.997–5.004
Activity reminding treatment 0.846 0.740–0.968
Difficulties remembering to take/use/remove the
contraceptive method
During the week, from Monday
to Friday
6.189 4.982–7.687 <0.0001
(reference: none) On vacation 2.132 1.851–2.455 <0.0001
On weekend 3.392 2.934–3.921 <0.0001
On short trips 1.563 1.306–1.871 <0.0001
Going out the night before 2.099 1.762–2.501 <0.0001
Travelling to a different time zone 1.403 1.106–1.780 <0.0001
Goodness-of-fit (Hosmer-Lemeshow): p-value = 0.7004.
Discrimination test: p-value = 0.7830.
Abbreviations: CI Confidence Interval.
Probability modeled is noncompliance (code = 1).
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about the factors associated with noncompliance to the
contraceptive method (pill, patch, vaginal ring), so the
health professional can recommend a change of treat-
ment that best suits the user profile.
Nevertheless, the study is subject to a series of limita-
tions. First its cross-sectional design means that it is not
possible to describe those factors that affect compliance;
making unable to predict outcomes or draw conclusions
about causal relationships. Second, as the study popula-
tion comprises young women who may have little ex-
perience of using combined hormonal contraceptives,
our findings cannot be extrapolated to other age groups.Third, a more accurate definition of compliance would
enable us to rule out any potential bias in the compari-
son of the 3 methods. Fourth, the used method of
assessing compliance was indirect, namely, by self-
administered questionnaire; therefore the resulting data
are not as objective as those obtained using more direct
methods.
Conclusions
The findings from this study conclude that more than half
of the women were noncompliant, but the frequency of
their noncompliance varied with the method used. Other
factors associated to increase the noncompliance were: high
Martínez-Astorquiza-Ortiz de Zarate et al. BMC Women's Health 2013, 13:38 Page 9 of 9
http://www.biomedcentral.com/1472-6874/13/38treatment duration, low level information treatment, poor
understanding of information and instructions, not interest
becoming pregnant, low partner’s support or absence of
partner, non-participation in the choice of contraceptive
method, low level of interest in a routine method or diffi-
culties remembering to take/use the contraceptive method.
Understanding the user’s reasons for noncompliance by the
clinician and encouraging a collaborative approach can go a
long way to improving compliance.
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